Amyloidosis-associated kidney disease

被引:306
作者
Dember, Laura M.
机构
[1] Boston Univ, Sch Med, Renal Sect, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Amyloid Treatment & Res Program, Boston, MA 02118 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 17卷 / 12期
关键词
D O I
10.1681/ASN.2006050460
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The amyloidoses are a group of disorders in which soluble proteins aggregate and deposit extracellularly in tissues as insoluble fibrils, causing progressive organ dysfunction. The kidney is one of the most frequent sites of amyloid deposition in AL, AA, and several of the hereditary amyloidoses. Amyloid fibril formation begins with the misfolding of an amyloidogenic precursor protein. The misfolded variants self-aggregate in a highly ordered manner, generating protofilaments that interact to form fibrils. The fibrils have a characteristic appearance by electron microscopy and generate birefringence under polarized light when stained with Congo red dye. Advances in elucidating the mechanisms of amyloid fibril formation, tissue deposition, and tissue injury have led to new and more aggressive treatment approaches for these disorders. This article reviews the pathogenesis, diagnosis, clinical manifestations, and treatment of the amyloidoses, focusing heavily on the renal aspects of each of these areas.
引用
收藏
页码:3458 / 3471
页数:14
相关论文
共 107 条
[1]
Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis [J].
Akar, H ;
Seldin, DC ;
Magnani, B ;
O'Hara, C ;
Berk, JL ;
Schoonmaker, C ;
Cabral, H ;
Dember, LM ;
Sanchorawala, V ;
Connors, LH ;
Falk, RH ;
Skinner, M .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2005, 12 (04) :210-215
[2]
Ancsin J B, 2001, Methods Mol Biol, V171, P449
[3]
PERSISTENT WATER DIURESIS IN RENAL AMYLOIDOSIS - A CASE-REPORT [J].
ASMUNDSSON, P ;
SNAEDAL, J .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1981, 15 (01) :77-79
[4]
Other glomerular pathologies in three patients with diabetes mellitus [J].
Balal, M ;
Paydas, S ;
Seyrek, N ;
Karayaylali, I ;
Gonlusen, G .
RENAL FAILURE, 2004, 26 (02) :185-188
[5]
Ostertag revisited: The inherited systemic amyloidoses without neuropathy [J].
Benson, MD .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2005, 12 (02) :75-87
[6]
Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein Al gene [J].
Booth, DR ;
Tan, SY ;
Booth, SE ;
Tennent, GA ;
Hutchinson, WL ;
Hsuan, JJ ;
Totty, NF ;
Truong, O ;
Soutar, AK ;
Hawkins, PN ;
Bruguera, M ;
Caballeria, J ;
Sole, M ;
Campistol, JM ;
Pepys, MB .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (12) :2714-2721
[7]
Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress [J].
Brenner, DA ;
Jain, M ;
Pimentel, DR ;
Wang, B ;
Connors, LH ;
Skinner, M ;
Apstein, CS ;
Liao, RL .
CIRCULATION RESEARCH, 2004, 94 (08) :1008-1010
[8]
Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features [J].
Bridoux, F ;
Hugue, V ;
Coldefy, O ;
Goujon, JM ;
Bauwens, M ;
Sechet, A ;
Preud'Homme, JL ;
Touchard, G .
KIDNEY INTERNATIONAL, 2002, 62 (05) :1764-1775
[9]
NEPHROGENIC DIABETES INSIPIDUS CAUSED BY AMYLOID DISEASE - EVIDENCE IN MAN OF THE ROLE OF THE COLLECTING DUCTS IN CONCENTRATING URINE [J].
CARONE, FA ;
EPSTEIN, FH .
AMERICAN JOURNAL OF MEDICINE, 1960, 29 (03) :539-544
[10]
High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal disease [J].
Casserly, LF ;
Fadia, A ;
Sanchorawala, V ;
Seldin, DC ;
Wright, DG ;
Skinner, M ;
Dember, LM .
KIDNEY INTERNATIONAL, 2003, 63 (03) :1051-1057